Since HO1 expression is protective against ICC loss, it has been theorized that macrophage HO1 induction could be a therapeutic target in reversing ICC loss and delayed gastric emptying [46,139]. The gene discussed is HMOX1; the disease is intrahepatic cholangiocarcinoma.